Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer
2018 ◽
2020 ◽
2016 ◽
Vol 111
◽
pp. 849-858
◽
2010 ◽
Vol 127
(1)
◽
pp. 69-80
◽
2008 ◽
Vol 109
(1-2)
◽
pp. 1-10
◽